Skip to main content
All lobbying filings

Van Scoyoc Associates

Van Scoyoc Associates filed a Q3 report for Quva Pharma, Inc. on October 19, 2026, reporting $50,000 in lobbying income.

Lobbying for Quva Pharma, Inc. · 503B outsourcing facility

As filed: VAN SCOYOC ASSOCIATES for QUVA PHARMA, INC.

All filings by Van Scoyoc Associates · Everything Quva Pharma, Inc. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Texas

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Pharmacy

Outsourcing facilities regulated under Section 503B under the Federal Food, Drug, and Cosmetic Act S.3794, SAFE Drugs Act of 2026, Entirety

 Bills named in this filing 1

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem